Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits
The results of this cohort study suggest that opioid prescribing limits are not associated with changes in postpartum opioid prescribing regardless of delivery type or opioid naivete, which is consistent with research findings on these limits in other conditions or settings. Future research could explore what kinds of prevention mechanisms reduce the risk of opioid prescribing during pregnancy and postpartum.
Authors
- Alvin D. Jeffery (ORCID: https://orcid.org/0000-0003-2797-6508)
- Lori Schirle (ORCID: https://orcid.org/0000-0003-2551-019X)
- Jake R. Morgan (ORCID: https://orcid.org/0000-0002-1559-3983)
- Sarah S. Osmundson (ORCID: https://orcid.org/0000-0002-7626-9992)
- Julia C. Phillippi (ORCID: https://orcid.org/0000-0002-6549-094X)
- Ashley A. Leech
- Carrie Fry (ORCID: https://orcid.org/0000-0003-0661-847X)
- Yixuan Li (ORCID: https://orcid.org/0000-0002-5997-6433)
- Manuel Horta
Institutions
- Boston University (US)
- Vanderbilt University (US)
- Vanderbilt Health (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1001/jamahealthforum.2024.4216
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Patient-Centered Outcomes Research Institute
- American Association of Nurse Anesthetists
- National Institutes of Health
- Agency for Healthcare Research and Quality
- National Institute on Drug Abuse